Talk to Your Pharmacist

In this episode, our guest is Our guest, Sonia Oskouei, PharmD, BCMAS, DPLA, joined Cardinal Health in June 2020 to lead the company’s biosimilar strategy. She most recently served as the Vice President of Innovation and Digital Health at Premier Inc., where she led their national biosimilars strategy on behalf of 4,000 where she partnered with pharmaceutical manufacturers and providers to create resources, and education to help health system stakeholders evaluate and adopt biosimilars.
Sonia is an established thought leader with numerous publications and currently serves on the Board of Advisors for the Center for Biosimilars. She holds a Doctor of Pharmacy from Belmont University.

Main Talking Points:
Commonly asked questions:
- What are biosimilars?
- How they are different than generics
- How long they have been approved in the U.S. (and the rest of the world)
- Why are they important (eg cost savings)
- Explaining the interchangeability designation + why it matters
- Understanding state regulations and how that will affect pharmacist adoption
- Current market dynamics and what is on the FDA horizon for future biosimilars

Host - Hillary Blackburn, PharmD, MBA
www.hillaryblackburn.com
https://www.linkedin.com/in/hillary-blackburn-67a92421/
@talktoyourpharmacist for Instagram and Facebook
@HillBlackburn Twitter

Show Notes

★ Support this podcast on Patreon ★

What is Talk to Your Pharmacist?

We're dispensing stories of success from across the continuum of care.

Talk to Your Pharmacist is a podcast for pharmacists, student pharmacists, and others across the country to hear from industry leaders about their leadership stories and current healthcare topics. The Talk to Your Pharmacist podcast was founded and hosted by pharmacist, Dr. Hillary Blackburn.